Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma [Phase 4]
A Phase 4 clinical trial evaluating digital monitoring of self-reported symptoms in patients with advanced renal cell carcinoma treated with…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of a CD70-targeted CAR-T therapy for CD70-positive advanced solid tumors is currently recruiting, enrolling patient…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer [Phase 2]
Phase 2 neoadjuvant immuno-oncology trial for primary clear cell renal cell carcinoma. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy [Phase 2]
Phase 2, prospective, single-arm multicenter study evaluating JS004 in combination with toripalimab for unresectable or advanced renal cell …
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC [Phase 2]
A randomized Phase II trial comparing nivolumab plus ipilimumab to standard of care in untreated and advanced non-clear cell renal cell carc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors [Phase 2]
Phase 2 clinical trial update for BL-B01D1 in patients with multiple solid tumors, including locally advanced or metastatic urinary system t…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma [Phase 4]
Phase 4 clinical trial evaluating cabozantinib in combination with nivolumab for older patients with renal cell carcinoma is currently recru…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Comparison of Outcomes and Surgical Time Between Cortical and Medullary Suture vs. Medullary-Only Suture: Cortex Clinical Trial [NA]
This clinical trial update reports a study comparing cortical and medullary suturing techniques versus medullary-only suturing in renal cell…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC) [Phase 1]
Phase 1 clinical trial updating on the effects of belzutifan on PET tracer uptake (89Zr-DFO-girentuximab) in patients with renal cell carcin…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery [Phase 2]
Phase 2 trial exploring adding CBM588 to pembrolizumab for renal cell carcinoma after surgery; the study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Registry Platform Urologic Cancer
An ongoing clinical trial update from iOMEDICO AG describing a recruiting study for renal cell carcinoma and urothelial carcinoma.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
This multicenter retrospective study uses CT-based radiomics to predict MIT family translocation kidney cancer in renal cell carcinoma.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study
Multicenter clinical trial update evaluating serological autoantibodies as biomarkers for early diagnosis and prognosis of renal cell carcin…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors [Phase 1]
Pfizer's PF-07820435 study in advanced solid tumors, including non-small-cell lung cancer and other indications, has been terminated at Phas…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer [Phase 1, Phase 2]
Scancell's Modi-1 Moditope is being studied in Phase 1/2 trials across several cancers, including triple-negative breast cancer, renal cell …
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
A clinical trial is evaluating the combination of PD-1/PD-L1 immune checkpoint inhibitors with radiotherapy across several cancers to assess…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC [Phase 2]
A Phase 2 clinical trial is evaluating preoperative therapy with super-selective tumor artery embolization combined with toripalimab and axi…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors [Phase 1, Phase 2]
An ongoing Phase 1/2 study investigates systemic VSV-IFNβ-NIS in combination with checkpoint inhibitors for select solid tumors. The trial i…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk [Phase 2]
A Phase 2 clinical trial is evaluating PET/CT-guided decisions to keep metastatic renal cell carcinoma patients free of systemic therapy. Th…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for GI-108, a bispecific anti-CD73-IL-2v fusion protein, being studied as monotherapy in advanced or metasta…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation [Phase 1]
A Phase 1 clinical trial is evaluating fecal microbiota transplantation to prevent toxicity in renal cell carcinoma patients treated with im…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Renal Tumour Imaging Using MRI [NA]
The document notes a University College London-sponsored MRI-based imaging trial for renal cancer that is currently active but not recruitin…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Retrospective Study on the Safety of Nivolumab in Patients With mRCC and Renal Failure
This clinical trial update provides a retrospective assessment of the safety of nivolumab in patients with metastatic renal cell carcinoma a…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A Multicenter Study of RUS NE [NA]
A multicenter clinical trial evaluating RUS NE for renal tumors is currently recruiting.
-
EMA approval · 2025-09-11EMA Authorised: Axitinib Accord (axitinib) — Accord Healthcare S.L.U.
The EMA authorised a new marketing authorisation for axitinib under the brand Axitinib Accord by Accord Healthcare S.L.U. for renal cell car…